Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 21 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-8.70 Insider Own19.12% Shs Outstand8.23M Perf Week-16.22%
Market Cap12.76M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float6.66M Perf Month-40.61%
Income-4.44M PEG- EPS next Q- Inst Own0.47% Short Float4.65% Perf Quarter-64.77%
Sales0.08M P/S159.46 EPS this Y- Inst Trans- Short Ratio0.24 Perf Half Y-79.39%
Book/sh-1.61 P/B- EPS next Y- ROA-157.25% Short Interest0.31M Perf Year-86.93%
Cash/sh0.02 P/C75.04 EPS next 5Y- ROE-421.71% 52W Range1.67 - 37.92 Perf YTD-51.56%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-95.91% Beta0.89
Dividend TTM- Quick Ratio0.15 Sales past 5Y35.02% Gross Margin-133.29% 52W Low-7.19% ATR (14)0.38
Dividend Ex-Date- Current Ratio0.15 EPS Y/Y TTM59.21% Oper. Margin-5395.95% RSI (14)30.27 Volatility8.45% 14.70%
Employees7 Debt/Eq- Sales Y/Y TTM68.59% Profit Margin-5275.34% Recom1.00 Target Price48.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q43.94% Payout- Rel Volume0.07 Prev Close1.67
Sales Surprise- EPS Surprise- Sales Q/Q4.63% EarningsAug 25 BMO Avg Volume1.29M Price1.55
SMA20-25.92% SMA50-47.93% SMA200-79.57% Trades Volume96,096 Change-7.19%
Feb-05-24 08:00AM
Jan-29-24 09:31AM
Jan-26-24 07:58AM
Jan-22-24 08:00AM
08:00AM Loading…
Jan-17-24 08:00AM
Jan-08-24 08:00AM
Jan-02-24 12:00PM
Nov-27-23 08:00AM
Nov-08-23 08:00AM
Nov-06-23 08:00AM
Nov-01-23 08:00AM
Oct-25-23 08:30AM
Oct-24-23 08:45AM
Oct-23-23 07:00AM
08:00AM Loading…
Oct-02-23 08:00AM
Aug-25-23 04:10PM
Jun-14-23 11:27AM
Jun-08-23 07:30AM
May-30-23 07:30AM
May-23-23 07:30AM
May-19-23 07:30AM
May-11-23 12:41PM
May-02-23 07:00AM
Apr-28-23 11:20AM
Apr-24-23 07:00AM
Mar-07-23 09:19AM
Feb-16-23 07:00AM
Feb-15-23 07:00AM
08:50AM Loading…
Feb-05-23 08:50AM
Jan-31-23 10:01AM
Jan-17-23 08:29AM
Dec-22-22 10:36AM
Dec-21-22 10:23AM
Dec-19-22 08:33AM
Dec-01-22 09:41AM
Nov-16-22 05:12AM
Oct-25-22 07:00AM
Oct-24-22 07:00AM
Oct-12-22 07:00AM
Oct-10-22 07:05AM
Oct-03-22 07:03AM
Sep-19-22 07:03AM
Aug-04-22 07:00AM
Jul-22-22 09:01AM
Jul-20-22 07:00AM
Jun-22-22 07:00AM
Apr-26-22 09:15PM
Apr-21-22 07:45PM
Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.